Overview

ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery

Status:
Unknown status

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to determine the effective dose of carbetocin which would prevent the occurrence of postpartum uterine atony in 90% of women undergoing an elective cesarean delivery.

Phase:

Phase 4

Details

Lead Sponsor:

Maisonneuve-Rosemont Hospital

Collaborator:

Université de Montréal

Treatments:

Carbetocin
Oxytocin